Similac Recall 2022 Lawsuit Information

8/8/2022 UPDATE: With dozens of Similac recall lawsuits filed in 2022 throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation (JPML) has established centralized pretrial proceedings for the cases before U.S. District Judge Matthew F. Kennelly in the Northern District of Illinois. While… Read More

Harvey Kirk

By
March 4, 2022 | 2 Comments

Xeljanz Cancer Risks Highlighted In Study Data

Serious Xeljanz cancer risks that have not been adequately disclosed by the drug makers have been recently uncovered in a completed study conducted by Pfizer. If earlier information and warnings had been provided for users about the Xeljanz cancer side effects, many individuals may have avoided… Read More

Harvey Kirk

By
February 8, 2021 | 2 Comments